Long-term outcomes of extending dual antiplatelet therapy after drug-eluting stent implantation for acute coronary syndrome: a large single-center study

References

• Windecker S, Windecker S, Kolh P, Alfonso F, Collet J, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541–2619. doi:10.1093/eurheartj/ehu278.
   PubMed Web of Science ®Google Scholar
• Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, L M, et al. ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2016;68:1082–1115. doi:10.1016/j.jtcvs.2016.07.044.
   PubMed Web of Science ®Google Scholar
• Chinese Society of Cardiology (CSC), Chinese College of Cardiovascular Physicians (CCCP)/Chinese Medical Doctor Association (CMDA), Editorial board of Chinese Journal of Cardiology 2016. guideline for percutaneous coronary intervention in China. Chin J Cardiol 2016;44(5):382–400. doi:10.3760/cma.j.issn.0253-3758.2016.05.006.
   Google Scholar
• Montalescot G, Brieger D, Dalby AJ, Park SJ, Mehran R. Duration of dual antiplatelet therapy after coronary stenting: A review of the evidence. J Am Coll Cardiol 2015;66:832–847. doi:10.1016/j.jacc.2015.05.053.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Clopidogrel in unstable angina to prevent recurrent events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494–502. doi:10.1056/NEJMoa010746.
   PubMed Web of Science ®Google Scholar
• Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2014;371:2155–2166. doi:10.1056/NEJMoa1409312.
   PubMed Web of Science ®Google Scholar
• Giustino G, Baber U, Sartori S, Mehran R, Mastoris I, Kini AS, Sharma SK, Pocock SJ, Dangas GD. Duration of dual antiplatelet therapy after drug-eluting stent implantation: A systematic review and meta-analysis of randomized controlled trials. J Am Coll Cardiol 2015;65:1298–1310. doi:10.1016/j.jacc.2015.01.039.
   PubMed Web of Science ®Google Scholar
• Palmerini T, Sangiorgi D, Valgimigli M, Biondi-Zoccai G, Feres F, Abizaid A, Costa RA, Hong MK, Kim BK, Jang Y, et al. Short-versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis. J Am Coll Cardiol 2015;65:1092–1102. doi:10.1016/j.jacc.2014.12.046.
   PubMed Web of Science ®Google Scholar
• Jaffe AS. Third universal definition of myocardial infarction. Clin Biochem 2013;46:1–4. doi:10.1016/j.clinbiochem.2012.10.036.
   PubMed Web of Science ®Google Scholar
• Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, Kaul S, Wiviott SD, Menon V, Nikolsky E, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 2011;123:2736–2747. doi:10.1161/CIRCULATIONAHA.110.009449.
   PubMed Web of Science ®Google Scholar
• Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, et al. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes. J Am Coll Cardiol 2014;64:e139–e228. doi:10.1016/j.jacc.2014.09.017.
   PubMed Web of Science ®Google Scholar
• Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, et al. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/ SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHAGuideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation 2016;134(10):e123–55. doi:10.1161/CIR.0000000000000404.
   Google Scholar
• Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, et al. ESC/EACTS guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35:2541–2619. doi:10.1093/eurheartj/ehu278.
   PubMed Web of Science ®Google Scholar
• Chinese Society of Cardiology (CSC), Chinese College of Cardiovascular Physicians (CCCP)/Chinese Medical Doctor Association (CMDA), Editorial board of Chinese Journal of Cardiology 2016. guideline for percutaneous coronary intervention in China. Chin J Cardiol 2016;44(5):382–400. doi:10.3760/cma.j.issn.0253-3758.2016.05.006.
   Google Scholar
• Mak KH, Bhatt DL, Shao M, Hankey GJ, Easton JD, Fox KA, Topol EJ. Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study. Am Heart J 2009 Apr;157(4):658–665. doi:10.1016/j.ahj.2008.08.031.
   PubMed Web of Science ®Google Scholar
• Kang J, Park KW, Palmerini T, Stone GW, Lee MS, Colombo A, Chieffo A, Feres F, Abizaid A, Bhatt DL, et al. Racial differences in ischaemia/bleeding risk trade-off during anti-platelet therapy: individual patient level landmark meta-analysis from seven RCTs. Thromb Haemost 2019 Jan;119(1):149–162. doi:10.1055/s-0038-1676545.
   PubMed Web of Science ®Google Scholar
• Li YH, Chiu YW, Cheng JJ, Hsieh IC, Lo PH, Lei MH, Ueng KC, Chiang FT, Sung SH, Kuo JY, et al.; Taiwan ACS STENT Registry Investigators. Duration of clopidogrel-based dual antiplatelet therapy and clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention - a real-world observation in Taiwan From 2012 to 2015. Circ J. 2019 May 24;83(6):1317–1323. doi: 10.1253/circj.CJ-18-1283.
   PubMed Web of Science ®Google Scholar
• Bonaca MP, Murphy SA, Miller D, Herrman JP, Gottlieb S, Keltai M, Menozzi A, Nicolau JC, Widimsky P, Antman EM, et al. Patterns of long-term thienopyridine therapy and outcomes in patients with acute coronary syndrome treated with coronary stenting: observations from the TIMI-38 Coronary Stent Registry. Clin Cardiol 2014 May;37(5):293–299. doi:10.1002/clc.22247.
   PubMed Web of Science ®Google Scholar
• Verdoia M, Kedhi E, Ceccon C, Suryapranata H, De Luca G. Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials. Int J Cardiol 2018 Aug 1;264:30–38. doi:10.1016/j.ijcard.2018.02.095.
   PubMed Web of Science ®Google Scholar
• Mehran R, Baber U, Steg PG, Ariti C, Weisz G, Witzenbichler B, Henry TD, Kini AS, Stuckey T, Cohen DJ, et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet 2013 Nov 23;382(9906);1714–1722. doi:10.1016/S0140-6736(13)61720-1.
   PubMed Web of Science ®Google Scholar